Silgan Strategic Portfolio Announcement - SILGAN HOLDINGS INC

Explicit Guidance:

• Revenue & EBITDA: Pro forma consolidated sales expected at approximately $10 billion and adjusted EBITDA of approximately $1.7 billion, inclusive of $225 million in expected synergies.
• Synergy Realization: $225 million in expected synergies targeted for Silgan MCC: $75 million in Year 1, $150 million in Year 2, and $225 million in Year 3.
• Synergy Cost: Estimated one-time integration costs of ~$225 million (1:1 ratio to synergies), with ~$100 million expected in the first two years and the balance in Year 3.
• EPS Accretion: Transaction expected to drive at least 15% accretion to adjusted EPS and free cash flow post-closing, inclusive of the 40% AIP minority interest.
• CapEx: Silgan MCC CapEx rate expected to remain stable at approximately 3% of total sales.
• Leverage: Silgan MCC net debt expected to be ~$4.6 billion (4.0x leverage post-synergies) with interest rates around 7% based on current forward curves; Dispensing Solutions to maintain ~1.8x net leverage.
• Transaction Timing: Expected closing in mid-2027.

Business-Segment Outlook:

• Silgan MCC (Metal Packaging): Formed by combining Silgan Metal Containers/food closures with Trivium. Will operate with an independent balance sheet and 60% ownership by Silgan (40% by AIP). Revenue profile of ~$7.3 billion with ~$1.2 billion adjusted EBITDA post-synergy.
• Dispensing Solutions: Remaining wholly-owned segment, expected to remain at ~1.8x leverage to fund growth. Targeted end markets include healthcare/pharma (high single-digit growth potential), fragrance/beauty (mid-single-digit growth), and home care/lawn & garden (low single-digit growth).
• Geographic & Product Mix: Combined network to produce >27 billion cans and >30 billion closures annually. New exposure added in Europe, aerosols, and aluminum beverage bottles via Trivium. Dispensing Solutions currently ~50% fragrance/beauty/personal care, ~20% home care, >10% healthcare.
• Acquisition Strategy: Dispensing Solutions to continue "balanced organic investments and disciplined capital deployment" with a strong M&A pipeline; Silgan MCC to pursue value-creating opportunities over time.

Market and Competitive Outlook:

• Competitive Dynamics: Metal packaging market driven by consumer need for affordability, sustainability, and supply reliability. Combined entity aims to be a "global premier packaging" platform to expand the overall market for metal packaging globally.
• Pricing & Supply: Focus on operational excellence to lower costs in price-sensitive markets; leveraging combined scale to enhance supplier negotiations and global supply chain reliability.
• Regulatory/Tariffs: Acknowledges increased influx of imported filled goods (approx. 80% of 10-plate products in US are imported) and tariff activities; positioning to support "American jobs" and local manufacturing relevance.
• Share Gains: Opportunity to cross-sell products (e.g., Trivium aerosols to Silgan food customers; Silgan closures to Trivium clients) and expand the product basket globally.

Macro / Industry Outlook:

• Economic Environment: Current forward curves reflect the prevailing higher interest rate environment (approx. 7%), which is factored into the EPS accretion calculation.
• Industry Trends: Shift toward longer-term contracts (3-5 years) in Europe compared to historical annual agreements; industry moving away from fiber/resin packaging in favor of metal for sustainability and low-cost nutrition.
• Capital Markets: Transaction structured to be leveraged neutral for the consolidated Silgan entity, avoiding meaningful incremental shareholder capital deployment.

Strategic Initiatives:

• Acquisition of Trivium: All-cash transaction valued at ~$3.4 billion, funded by ~$1 billion AIP equity, third-party debt for Silgan MCC, and ~$2.3 billion cash proceeds to Silgan.
• Partnership: AIP to hold 40% equity in Silgan MCC, providing capital and strategic alignment to execute integration and synergy capture.
• Separation Pathway: Explicit plan for Silgan MCC to potentially become an independent public company via a tax-free distribution. Timing contingent on synergy realization, business readiness, and market conditions.
• Capital Allocation Optimization: Reallocating balance sheet to unlock ~$2.3 billion cash for Silgan, increasing financial flexibility to invest in faster-growing Dispensing Solutions.

Risks and Headwinds to Outlook:

• Integration & Synergy Execution: Synergy targets ($225M) depend on successful integration and operational improvements; actual results may differ due to execution risks.
• Regulatory Approval: Transaction requires approval; while overlap exists in food cans, management believes the combination is highly complementary with distinct geographic strengths (US vs. Europe).
• Market Conditions: Separation timing is subject to "market conditions" and the readiness of the businesses post-integration.
• Interest Rates: Leverage and debt costs are sensitive to prevailing forward curves and refinancing maturities.
• Minority Interest: EPS accretion calculations include the 40% AIP minority interest, which impacts the net benefit to Silgan shareholders.

Management Tone on the Future:

• Confidence: Management expresses "high confidence" in the magnitude and timing of synergies, citing a "rigorous bottom-up diligence process."
• Strategic Clarity: Describes the deal as a "transformative step" and "best-in-class global platform" that aligns with decades of disciplined value creation.
• Cautious Optimism: Emphasizes that separation will only occur "once the business is ready" and "markets are tuned," prioritizing synergy capture over immediate restructuring.
• Capital Discipline: Reaffirms commitment to a "disciplined, returns-based capital allocation process" with no fundamental change to the strategy, despite the structural separation.

Miscellaneous:

• Transaction Structure: Silgan will consolidate 100% of Silgan MCC results but retains only 60% equity ownership; the transaction is leveraged neutral on a consolidated basis.
• Non-GAAP Metrics: Adjusted EBITDA and Adjusted EBIT are used for guidance; reconciliation available in investor relations materials.
• Cost of Equity: Management noted that current equity valuations made a traditional equity-funded approach less attractive, necessitating the AIP partnership structure.